X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 53 filers reported holding X4 PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,648,000 | -18.6% | 311,492 | 0.0% | 11.70% | +260.5% |
| Q2 2021 | $2,025,000 | -24.5% | 311,492 | 0.0% | 3.24% | -6.7% |
| Q1 2021 | $2,682,000 | +33.9% | 311,492 | 0.0% | 3.48% | +33.1% |
| Q4 2020 | $2,003,000 | -5.0% | 311,492 | 0.0% | 2.61% | -24.8% |
| Q3 2020 | $2,109,000 | -27.4% | 311,492 | 0.0% | 3.48% | +53.9% |
| Q2 2020 | $2,903,000 | -6.8% | 311,492 | 0.0% | 2.26% | -19.9% |
| Q1 2020 | $3,115,000 | -6.5% | 311,492 | 0.0% | 2.82% | +16.3% |
| Q4 2019 | $3,333,000 | -15.8% | 311,492 | 0.0% | 2.42% | +7.7% |
| Q3 2019 | $3,959,000 | -15.3% | 311,492 | 0.0% | 2.25% | -38.7% |
| Q2 2019 | $4,672,000 | -13.8% | 311,492 | 0.0% | 3.67% | -20.0% |
| Q1 2019 | $5,423,000 | – | 311,492 | – | 4.59% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |